A Wyss Center spin-in programming network dynamics in the brain
First generative neuromodulation platform
Dandelion Science, a start-up supported by the Wyss Center, is creating the world’s first generative neuromodulation platform to treat the brain.
Most treatments for brain disorders targeting neurochemistry have broad and often deleterious effects on neurofunction. Dandelion Science is developing a platform to program network dynamics in the brain in a non-invasive way. The platform harnesses the power of generative artificial intelligence to synthesize, on demand, precision sensory stimulation therapies to address neurodegenerative and neuropsychiatric disorders.
Clee Medical’s technology addresses critical challenges in neurosurgical procedures by delivering real-time, ultra-high-resolution imaging to guide surgeons with unmatched precision. Leveraging artificial intelligence and machine learning, the system enables the detection of intricate neuroanatomy and vasculature, ensuring safe and targeted access to delicate areas of the brain. This solution represents a significant leap in the accuracy and efficiency of neurosurgical interventions.
“Generative neuromodulation is poised to become a multi-billion-dollar market in the coming years. Dandelion’s approach holds promise for developing therapies that precisely match the complex dysfunctions they are intended to treat.”
“We are delighted to invest in and partner with Dandelion Science. The promise of generative AI as a new therapeutic paradigm for brain disorders is exciting. We look forward to the transformative impact this technology could have on patients worldwide.”
